Glidian

Glidian operates as a technology-driven platform focused on automating and streamlining the prior authorization process for healthcare providers, a critical function known for causing significant administrative burdens and delays in patient care. Founded in 2016 by Ashish Dua, Robert Romano, and Maxwell Wu, the company was established to address the inefficiencies of manual, paper-based authorization submissions to insurance companies. The founding team's background is rooted in engineering and technology; CEO Ashish Dua and COO Robert Romano met as biomedical engineering students at Johns Hopkins University, bringing expertise in medical technology and software development. Their third co-founder has a background in machine learning and AI from Stanford, which informed the platform's intelligent data processing capabilities.

The company's core business revolves around a SaaS platform that integrates directly with a vast network of medical insurance payers. This allows healthcare providers, including hospitals, ambulatory practices, and diagnostic laboratories, to manage and submit prior authorization requests from a single, consolidated dashboard, eliminating the need to navigate multiple payer-specific portals, faxes, and phone calls. The platform supports various integration methods such as API, HL7, and X12 278, enabling seamless connection with existing Electronic Health Record (EHR) systems. Revenue is generated by providing these technology solutions and services to healthcare providers. The system auto-populates forms, tracks submission statuses in real-time, provides notifications, and uses an intelligent rules engine to suggest actions that increase the likelihood of first-attempt approvals, thereby reducing denials.

A significant milestone in Glidian's history was its acquisition by Infinx, a provider of AI-powered revenue cycle management solutions, on March 17, 2025. This strategic merger was intended to combine Glidian's specialized laboratory and provider-focused automation with Infinx's broader patient access and AI capabilities, creating a more powerful, comprehensive service offering. Before the acquisition, Glidian had participated in a Seed funding round in January 2019, led by Alchemist Accelerator, and had secured a total of $9.5M from investors including Tau Ventures, 1984 Ventures, and A-Level Capital. Annually, the platform processes over one million authorizations for more than 92,000 providers across all 50 states, demonstrating its extensive reach and impact on improving operational efficiency and accelerating patient care.

Keywords: prior authorization automation, healthcare administration, revenue cycle management, healthtech, medical billing, payer integration, provider solutions, patient access, laboratory services, RCM, electronic prior authorization, claims management, denial prevention, healthcare workflow, interoperability, medical insurance processing, clinical documentation, financial clearance, EHR integration, HIPAA compliant